The CAR-T Therapy Shift: Redefining Second-Line Treatment Strategies in Multiple Myeloma

home / meeting-of-the-minds / the-car-t-therapy-shift-redefining-second-line-treatment-strategies-in-multiple-myeloma

Meeting of the Minds video series features an actor portrayal of a hypothetical patient profile developed for educational purposes by leading oncology experts, based on characteristics of patients with various cancer types as seen in clinical practice.

Meet Sarah, a 55-year-old Businesswoman With Multiple Myeloma Considering CAR-T Therapy With Ide-cel

EP. 1: Meet Sarah, a 55-year-old Businesswoman With Multiple Myeloma Considering CAR-T Therapy With Ide-cel

Rahul Banerjee, MD, FACP ;Saad Z. Usmani, MD, MBA, FACP, FASCO;Binod Dhakal, MD ;Krystle Peterson, PA-C
December 23rd 2024
Managing Adverse Events with CAR T-Cell Therapy: Best Practices for Myeloma Care Teams

EP. 2: Managing Adverse Events with CAR T-Cell Therapy: Best Practices for Myeloma Care Teams

Rahul Banerjee, MD, FACP ;Saad Z. Usmani, MD, MBA, FACP, FASCO;Binod Dhakal, MD ;Krystle Peterson, PA-C
December 23rd 2024
Managing Neurotoxicities in CAR T: Clinical Approaches and Patient/Caregiver Education

EP. 3: Managing Neurotoxicities in CAR T: Clinical Approaches and Patient/Caregiver Education

Rahul Banerjee, MD, FACP ;Saad Z. Usmani, MD, MBA, FACP, FASCO;Binod Dhakal, MD ;Krystle Peterson, PA-C
January 31st 2025

This video segment explores the challenges of managing neurologic toxicities, including ICANS, in CAR-T therapy, highlighting monitoring strategies, tools for early detection, and approaches to communicating risks with patients and caregivers.

QOL Considerations for Optimal Patient Outcomes with CAR-T Therapy

EP. 4: QOL Considerations for Optimal Patient Outcomes with CAR-T Therapy

Rahul Banerjee, MD, FACP ;Saad Z. Usmani, MD, MBA, FACP, FASCO;Binod Dhakal, MD ;Krystle Peterson, PA-C
January 31st 2025

This video segment discusses strategies to help CAR-T therapy patients maintain quality of life, focusing on lifestyle support, balancing work during and after treatment, and effective supportive care measures.

Getting to Know Robert, a 72-Year-Old Retired Teacher Facing a Myeloma Relapse and Considering CAR-T Therapy with Cilta-cel

EP. 5: Getting to Know Robert, a 72-Year-Old Retired Teacher Facing a Myeloma Relapse and Considering CAR-T Therapy with Cilta-cel

Rahul Banerjee, MD, FACP ;Saad Z. Usmani, MD, MBA, FACP, FASCO;Binod Dhakal, MD ;Krystle Peterson, PA-C
February 7th 2025

This video segment profiles a 72-year-old retired science teacher with multiple myeloma, detailing his treatment journey from VRd induction and ASCT to relapse, management of comorbidities, and receiving cilta-cel, supported by his active and healthy wife.

Long-Term CAR-T Management in Myeloma: Collaborative Care and Monitoring Strategies for Patients Like Robert

EP. 6: Long-Term CAR-T Management in Myeloma: Collaborative Care and Monitoring Strategies for Patients Like Robert

Rahul Banerjee, MD, FACP ;Saad Z. Usmani, MD, MBA, FACP, FASCO;Binod Dhakal, MD ;Krystle Peterson, PA-C
February 7th 2025

This video segment examines protocols for long-term monitoring of CAR-T therapy patients, differences between academic and community settings, emerging adverse events, and strategies for multidisciplinary collaboration and care coordination to ensure seamless communication and continuity of care.

Life After CAR T Therapy: Insights for Patients and Referring Oncologists

EP. 7: Life After CAR T Therapy: Insights for Patients and Referring Oncologists

Rahul Banerjee, MD, FACP ;Saad Z. Usmani, MD, MBA, FACP, FASCO;Binod Dhakal, MD ;Krystle Peterson, PA-C
February 14th 2025

This video segment focuses on key elements of patient education and support for long-term CAR-T survivors, strategies to maintain quality of life and manage late effects, differences in supportive care needs between ide-cel and cilta-cel recipients, and approaches to fostering collaboration between academic centers and community practices for optimal long-term care.